Nobuo Maseki

5.1k total citations · 1 hit paper
90 papers, 4.0k citations indexed

About

Nobuo Maseki is a scholar working on Hematology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Nobuo Maseki has authored 90 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 30 papers in Molecular Biology and 26 papers in Pathology and Forensic Medicine. Recurrent topics in Nobuo Maseki's work include Acute Myeloid Leukemia Research (34 papers), Lymphoma Diagnosis and Treatment (24 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Nobuo Maseki is often cited by papers focused on Acute Myeloid Leukemia Research (34 papers), Lymphoma Diagnosis and Treatment (24 papers) and Chronic Lymphocytic Leukemia Research (20 papers). Nobuo Maseki collaborates with scholars based in Japan, United Kingdom and United States. Nobuo Maseki's co-authors include Yasuhiko Kaneko, T Kozu, Misao Ohki, M Sakurai, Masafumi Ohki, Masaharu Sakurai, Hiroyuki Miyoshi, Kimiko Shimizu, N Kamada and Hirofumi Kobayashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nobuo Maseki

86 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

1991 746 citations Nobuo Maseki et al. profile →

Peers

Nobuo Maseki

HEMAT

PFM

ONCOL

PHEOH

Masashi Sanada Japan

CR Bartram Germany

John Swansbury United Kingdom

R.S.K. Chaganti United States

WM Crist United States

Sabine Strehl Austria

Richard Garand France

S.C. Jhanwar United States

J Finan United States

A. Thomas Look United States

Masashi Sanada Japan

Nobuo Maseki

2.2k ×1.0

1.3k ×0.7

HEMAT

441 ×0.5

PFM

633 ×0.8

ONCOL

369 ×0.5

PHEOH

Citations per year, relative to Nobuo Maseki Nobuo Maseki (= 1×) peers Masashi Sanada

Countries citing papers authored by Nobuo Maseki

Since Specialization

Citations

This map shows the geographic impact of Nobuo Maseki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Maseki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Maseki more than expected).

Fields of papers citing papers by Nobuo Maseki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Maseki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Maseki. The network helps show where Nobuo Maseki may publish in the future.

Co-authorship network of co-authors of Nobuo Maseki

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Maseki. A scholar is included among the top collaborators of Nobuo Maseki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Maseki. Nobuo Maseki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sekiguchi, Yasunobu, Ayumi Gomyo, Nobuo Maseki, et al.. (2023). Use of R-mini-CHP in combination with polatuzumab vedotin (pola-R-mini-CHP) as the primary treatment in ≥80-year-old cases with diffuse large B-cell lymphoma. Journal of Clinical and Experimental Hematopathology. 63(4). 262–265. 1 indexed citations

Fukano, Reiji, Tetsuya Mori, Naoto Fujita, et al.. (2019). Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma. International Journal of Hematology. 110(6). 723–728. 8 indexed citations

Watanabe, Takashi, Kensei Tobinai, Taro Shibata, et al.. (2011). Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial. Journal of Clinical Oncology. 29(30). 3990–3998. 45 indexed citations

Okabe‐Kado, Junko, Takashi Kasukabe, Yoshio Honma, et al.. (2009). Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells. Cancer Science. 100(10). 1885–1894. 26 indexed citations

Yamaguchi, Motoko, Masahiko Oguchi, Kensei Tobinai, et al.. (2005). Phase I/II Study of Concurrent Chemoradiotherapy for Newly-Diagnosed, Localized Nasal NK/T-Cell Lymphoma: Results of a Phase I Portion of JCOG0211-DI.. Blood. 106(11). 2685–2685. 7 indexed citations

Tanimoto, Tetsuya, Takuhiro Yamaguchi, Yuji Tanaka, et al.. (2004). Comparative analysis of clinical outcomes after allogeneic bone marrow transplantationversusperipheral blood stem cell transplantation from a related donor in Japanese patients. British Journal of Haematology. 125(4). 480–493. 27 indexed citations

Namiki, Takeshi, Akiko Sakashita, Hirofumi Kobayashi, et al.. (2003). Clinical and Genetic Characteristics of Japanese Burkitt Lymphomas with or without Leukemic Presentation. International Journal of Hematology. 77(5). 490–498. 8 indexed citations

Izumo, Toshiyuki, et al.. (2000). Practical Utility of the Revised European‐American Classification of Lymphoid Neoplasms for Japanese Non‐Hodgkin's Lymphomas. Japanese Journal of Cancer Research. 91(3). 351–360. 14 indexed citations

Motoji, Toshiko, Isamu Sugawara, Yanhua Wang, et al.. (2000). Significance of lung resistance‐related protein in the clinical outcome of acute leukaemic patients with reference to P‐glycoprotein. British Journal of Haematology. 110(2). 370–378. 14 indexed citations

10.

Nakadate, Hisaya, Takashi Tsuchiya, Nobuo Maseki, et al.. (1999). Correlation of chromosome abnormalities with presence or absence ofWT1 deletions/mutations in Wilms tumor. Genes Chromosomes and Cancer. 25(1). 26–32. 13 indexed citations

11.

Kobayashi, Hirofumi, Nobuo Maseki, Akiko Sakashita, et al.. (1999). Mixed-lineage leukemia with t(10;11)(p13;q21): An analysis ofAF10-CALM andCALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes and Cancer. 25(1). 33–39. 38 indexed citations

12.

Kobayashi, Hirofumi, Fumie Hosoda, Nobuo Maseki, et al.. (1997). Hematologic malignancies with the t(10;11)(p13;q21) have the same molecular event and a variety of morphologic or immunologic phenotypes. Genes Chromosomes and Cancer. 20(3). 253–259. 35 indexed citations

13.

Izumo, Toshiyuki, Nobuo Maseki, & Yasuhiko Kaneko. (1996). An evaluation of REAL classification on malignant lymphomas in Japan.. 36(3). 145–156. 2 indexed citations

14.

Takeda, Osamu, Masafumi Handa, Takayuki Uehara, et al.. (1996). An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas. British Journal of Cancer. 74(10). 1620–1626. 30 indexed citations

15.

Kobayashi, Hirofumi, Noriko Satake, Nobuo Maseki, Akiko Sakashita, & Yasuhiko Kaneko. (1996). The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. British Journal of Haematology. 94(1). 105–111. 47 indexed citations

16.

Kaneko, Yasuhiko, Osamu Takeda, Chieko Homma, et al.. (1993). Deletion of WT1 and WIT1 Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan. Japanese Journal of Cancer Research. 84(6). 616–624. 7 indexed citations

17.

Shimizu, Kimiko, Hitoshi Ichikawa, Hiroyuki Miyoshi, et al.. (1991). Molecular assignment of a translocation breakpoint in acute myeloid leukemia with t(8;21). Genes Chromosomes and Cancer. 3(3). 163–167. 23 indexed citations

18.

Kaneko, Yasuhiko, N Kanda, Nobuo Maseki, et al.. (1990). Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study.. Journal of Clinical Oncology. 8(12). 2005–2013. 70 indexed citations

19.

Nakamura, Yuichi, Osamu Miura, Yuichi Sugahara, et al.. (1989). DNA rearrangement and restriction fragment length polymorphism within the first BCR intron in philadelphia‐positive acute leukemia. American Journal of Hematology. 32(1). 24–29. 1 indexed citations

20.

Sampi, K, et al.. (1989). Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia. Medical Oncology and Tumor Pharmacotherapy. 6(4). 291–296. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact